Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells

Breast Cancer Research and Treatment

Volumn 112, Issue 2, 2008, Pages 217-227

  Zhang, Haijun ^a,b   Liu, Gang ^a   Dziubinski, Michele ^a   Yang, Zengquan ^a   Ethier, Stephen P ^a   Wu, Guojun ^a,c  

^a KARMANOS CANCER INSTITUTE   (United States)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; PIK3CA; Somatic mutation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; EPIDERMAL GROWTH FACTOR; MATRIGEL; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PROTEIN KINASE B; PROTEIN P70;

ARTICLE; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL GROWTH; CELL INVASION; CELL MUTANT; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LENTIVIRINAE; MORPHOGENESIS; ONCOGENE; PIK3CA GENE; PRIORITY JOURNAL; SOMATIC MUTATION; WILD TYPE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMONES; COLLAGEN; DRUG COMBINATIONS; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; HUMANS; LAMININ; LENTIVIRUS; MAMMARY GLANDS, HUMAN; MORPHOLINES; MUTATION; PROTEOGLYCANS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA;

EID: 53949099847     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9847-6     Document Type: Article

References (39)

1. SJ Leevers B Vanhaesebroeck MD Waterfield 1999 Signalling through phosphoinositide 3-kinases: the lipids take centre stage Curr Opin Cell Biol 11 2 219 225
2. I Vivanco CL Sawyers 2002 The phosphatidylinositol 3-Kinase AKT pathway in human cancer Nat Rev Cancer 2 7 489 501
3. AG Bader S Kang L Zhao PK Vogt 2005 Oncogenic PI3K deregulates transcription and translation Nat Rev Cancer 5 12 921 929
4. LC Cantley 2002 The phosphoinositide 3-kinase pathway Science 296 5573 1655 1657
5. PT Hawkins KE Anderson K Davidson LR Stephens 2006 Signalling through Class I PI3Ks in mammalian cells Biochem Soc Trans 34 Pt 5 647 662
6. S Knuutila AM Bjorkqvist K Autio M Tarkkanen M Wolf O Monni J Szymanska ML Larramendy J Tapper H Pere 1998 DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies Am J Pathol 152 5 1107 1123
7. ML Larramendy T Lushnikova AM Bjorkqvist II Wistuba AK Virmani N Shivapurkar AF Gazdar S Knuutila 2000 Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines Cancer Genet Cytogenet 119 2 132 138
8. PH Rooney GI Murray DA Stevenson NE Haites J Cassidy HL McLeod 1999 Comparative genomic hybridization and chromosomal instability in solid tumours Br J Cancer 80 5-6 862 873
9. YY Ma SJ Wei YC Lin JC Lung TC Chang J Whang-Peng JM Liu DM Yang WK Yang CY Shen 2000 PIK3CA as an oncogene in cervical cancer Oncogene 19 23 2739 2744
10. A Racz N Brass D Heckel S Pahl K Remberger E Meese 1999 Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma Eur J Cancer 35 4 641 646
11. R Redon D Muller K Caulee K Wanherdrick J Abecassis S du Manoir 2001 A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains Cancer Res 61 10 4122 4129
12. L Shayesteh Y Lu WL Kuo R Baldocchi T Godfrey C Collins D Pinkel B Powell GB Mills JW Gray 1999 PIK3CA is implicated as an oncogene in ovarian cancer Nat Genet 21 1 99 102
13. Y Samuels Z Wang A Bardelli N Silliman J Ptak S Szabo H Yan A Gazdar SM Powell GJ Riggins 2004 High frequency of mutations of the PIK3CA gene in human cancers Science 304 5670 554
14. KE Bachman P Argani Y Samuels N Silliman J Ptak S Szabo H Konishi B Karakas BG Blair C Lin 2004 The PIK3CA gene is mutated with high frequency in human breast cancers Cancer Biol Ther 3 8 772 775
15. IG Campbell SE Russell DY Choong KG Montgomery ML Ciavarella CS Hooi BE Cristiano RB Pearson WA Phillips 2004 Mutation of the PIK3CA gene in ovarian and breast cancer Cancer Res 64 21 7678 7681
16. LH Saal K Holm M Maurer L Memeo T Su X Wang JS Yu PO Malmstrom M Mansukhani J Enoksson 2005 PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma Cancer Res 65 7 2554 2559
17. G Wu M Xing E Mambo X Huang J Liu Z Guo A Chatterjee D Goldenberg SM Gollin S Sukumar 2005 Somatic mutation and gain of copy number of PIK3CA in human breast cancer Breast Cancer Res 7 5 R609 616
18. SJ Isakoff JA Engelman HY Irie J Luo SM Brachmann RV Pearline LC Cantley JS Brugge 2005 Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells Cancer Res 65 23 10992 11000
19. JJ Zhao Z Liu L Wang E Shin MF Loda TM Roberts 2005 The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells Proc Natl Acad Sci USA 102 51 18443 18448
20. J Debnath SK Muthuswamy JS Brugge 2003 Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures Methods 30 3 256 268
21. GY Lee PA Kenny EH Lee MJ Bissell 2007 Three-dimensional culture models of normal and malignant breast epithelial cells Nat Methods 4 4 359 365
22. KR Shaw CN Wrobel JS Brugge 2004 Use of three-dimensional basement membrane cultures to model oncogene-induced changes in mammary epithelial morphogenesis J Mammary Gland Biol Neoplasia 9 4 297 310
23. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70
24. AG Bader S Kang PK Vogt 2006 Cancer-specific mutations in PIK3CA are oncogenic in vivo Proc Natl Acad Sci USA 103 5 1475 1479
25. S Kang AG Bader PK Vogt 2005 Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic Proc Natl Acad Sci USA 102 3 802 807
26. Y Samuels LA Diaz Jr. O Schmidt-Kittler JM Cummins L Delong I Cheong C Rago DL Huso C Lengauer KW Kinzler 2005 Mutant PIK3CA promotes cell growth and invasion of human cancer cells Cancer Cell 7 6 561 573
27. M Gymnopoulos MA Elsliger PK Vogt 2007 Rare cancer-specific mutations in PIK3CA show gain of function Proc Natl Acad Sci USA 104 13 5569 5574
28. J Debnath SJ Walker JS Brugge 2003 Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner J Cell Biol 163 2 315 326
29. KM Woods Ignatoski DL Livant S Markwart NK Grewal SP Ethier 2003 The role of phosphatidylinositol 3'-kinase and its downstream signals in erbB-2-mediated transformation Mol Cancer Res 1 7 551 560
30. XN Guo A Rajput R Rose J Hauser A Beko K Kuropatwinski C LeVea RM Hoffman MG Brattain J Wang 2007 Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model Cancer Res 67 12 5851 5858
31. MJ Arboleda JF Lyons FF Kabbinavar MR Bray BE Snow R Ayala M Danino BY Karlan DJ Slamon 2003 Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells Cancer Res 63 1 196 206
32. SA Eccles 2001 The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis J Mammary Gland Biol Neoplasia 6 4 393 406
33. A Enomoto H Murakami N Asai N Morone T Watanabe K Kawai Y Murakumo J Usukura K Kaibuchi M Takahashi 2005 Akt/PKB regulates actin organization and cell motility via Girdin/APE Develop Cell 9 3 389 402
34. HY Irie RV Pearline D Grueneberg M Hsia P Ravichandran N Kothari S Natesan JS Brugge 2005 Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition J Cell Biol 171 6 1023 1034
35. YM Li Y Pan Y Wei X Cheng BP Zhou M Tan X Zhou W Xia GN Hortobagyi D Yu 2004 Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis Cancer Cell 6 5 459 469
36. M Tan P Li KS Klos J Lu KH Lan Y Nagata D Fang T Jing D Yu 2005 ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis Cancer Res 65 5 1858 1867
37. J Luo BD Manning LC Cantley 2003 Targeting the PI3K-Akt pathway in human cancer: rationale and promise Cancer Cell 4 4 257 262
38. P Workman 2004 Inhibiting the phosphoinositide 3-kinase pathway for cancer treatment Biochem Soc Trans 32 Pt 2 393 396
39. R Bianco I Shin CA Ritter FM Yakes A Basso N Rosen J Tsurutani PA Dennis GB Mills CL Arteaga 2003 Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors Oncogene 22 18 2812 2822